Metraipolis › archive › dc_3e5fe06e5876
QSAR-guided discovery of novel KRAS inhibitors for lung cancer therapy — Europe PMC PMID:41333851
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41333851
- DOI
- 10.3389/fbinf.2025.1663846
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T12:19:47.236Z
- SHA-256 of the archived text
218750df398aec837d7dafe7c784282293953c320339953092e85ed5591ff387- Stable URL of this page
https://metraipolis.com/documento/dc_3e5fe06e5876
How to cite
QSAR-guided discovery of novel KRAS inhibitors for lung cancer therapy — Europe PMC PMID:41333851 — Europe PMC (en), https://europepmc.org/article/MED/41333851 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3e5fe06e5876 (Metraipolis archive dc_3e5fe06e5876, sha256 218750df398aec837d7dafe7c784282293953c320339953092e85ed5591ff387)
BibTeX
@misc{dc3e5fe06e5876,
title = {QSAR-guided discovery of novel KRAS inhibitors for lung cancer therapy — Europe PMC PMID:41333851},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41333851},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3e5fe06e5876; sha256 218750df398aec837d7dafe7c784282293953c320339953092e85ed5591ff387},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41333851. Agents can read the archived copy with the MCP tool read_document.